Correspondence re: Duffield-Lillico et al., Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. 11: 630-639, 2002.
Year: 2003
Type: letter
Abstract: Duffield-Lillico et al . [(1)][1] recently updated cancer incidence estimates among patients with nonmelanoma skin cancer randomized to receive either 200 μg/die (organic?) selenium as selenized yeast or placebo. They reported that an increase of only 25 months of follow-up attenuated the
Source: PubMed
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2281125112
